2024年5月2日 · What is The Octave MSDA Test & what is in the report? The Octave MSDA Test measures the levels of 18 proteins in your blood. The results are presented in a report shared …
Octave’s blood test accurately captures MS disease activity: Study
2023年9月6日 · The MSDA test had an AUROC of 0.781 for identifying inflamed lesions, 0.75 for new or enlarging lesions, and 0.768 for overall disease activity.
Octave Bioscience MS Disease Activity Test Gets Clinical Validation
2023年9月8日 · Created to address this unmet need, the Octave MSDA Test is a multi-protein serum-based biomarker assay designed to quantitatively measure the disease activity of …
Proteomic Biomarker Panel for Gauging Multiple Sclerosis Disease ...
2025年3月24日 · The multivariate proteomic Multiple Sclerosis Disease Activity (MSDA) test has been analytically and clinically validated. Methods: This is a single-center retrospective case …
ATSC member organizations represent the broadcast, professional equipment, motion picture, consumer electronics, computer, cable, satellite, and semiconductor industries. ATSC also …
Patients - OctaveBio
Octave’s Multiple Sclerosis Disease Activity (MSDA) Test enables you to measure this activity through a simple blood test based on the levels of 18 proteins in the blood that gives you a …
Serum-based Assay Validated for Care of Patients With MS
2023年11月1日 · The MSDA Test was designed to favor sensitivity over specificity. It can help identify patients with subradiographic and subclinical MS, permitting more timely treatment. As …
Gauging MS Disease Activity Through Octave’s MSDA
2023年2月24日 · There have been several different approaches introduced to better solve this issue, including Octave Bio’s multi-protein Multiple Sclerosis Disease Activity (MSDA) test. …
Utilizing Biomarker Panels to Effectively Gauge, Manage Multiple …
2023年3月6日 · Analytically and clinically validated, this test utilizes an algorithm that contains 18 biomarkers to produce 4 disease pathway scores covering immunomodulation, …
MSDA Test Identified as Biomarker-Based Instrument to Assess …
2022年2月25日 · The Multiple Sclerosis Disease Activity (MSDA) test can assist in monitoring therapeutic response to glatiramer acetate (GA) and biologic agents as a biomarker-based …